A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration

Publisher： Karger

E-ISSN： 1663-2699|7|1|230-236

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.7, Iss.1, 2016-04, pp. : 230-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anterior Chamber Paracentesis Might Prevent Sustained Intraocular Pressure Elevation after Intravitreal Injections of Ranibizumab for Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 52, Iss. 4, 2014-11 ,pp. : 234-238

Karger

Access to resources Recommend Favorite

Comparison of pro re nata versus Bimonthly Injection of Intravitreal Aflibercept for Typical Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 238, Iss. 1-2, 2017-04 ,pp. : 17-22

Karger

Access to resources Recommend Favorite

Three-Year Visual Outcome and Injection Frequency of Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 230, Iss. 1, 2013-04 ,pp. : 27-33

Karger

Access to resources Recommend Favorite

Long-Term Intraocular Pressure Changes in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab

By  

Ophthalmologica, Vol. 229, Iss. 3, 2013-03 ,pp. : 168-172

Karger

Access to resources Recommend Favorite

One-Year Outcomes of 1 + pro re nata versus 3 + pro re nata Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 237, Iss. 2, 2017-02 ,pp. : 105-110

Karger

Access to resources Recommend Favorite